Endocardium in Hypoplastic Left Heart Syndrome: Implications from In Vitro Study

Area of Science:

• Cardiovascular Biology
• Developmental Biology
• Stem Cell Research

Background:

• The endocardium, lining the heart ventricle, is crucial for valve formation but its role in hypoplastic left heart syndrome (HLHS) is not fully understood.
• Abnormalities like endocardial fibroelastosis (EFE) and valve malformations are linked to HLHS, yet molecular mechanisms in endocardial cells remain understudied.

Purpose of the Study:

• To review current in vitro studies utilizing induced pluripotent stem cells (iPSCs) to investigate endocardial pathology in HLHS.
• To emphasize novel findings on cellular phenotypes and molecular mechanisms contributing to HLHS endocardial defects.

Main Methods:

• Review of existing literature on in vitro studies of HLHS using iPSC technology.
• Analysis of research focusing on endocardial cell phenotypes and molecular pathways in HLHS models.

Main Results:

• iPSC-based models offer a powerful platform for studying genetic diseases like HLHS.
• These models reveal specific cellular phenotypes and molecular alterations in endocardial cells relevant to HLHS pathology.
• Current research is beginning to elucidate the molecular underpinnings of endocardial dysfunction in HLHS.

Conclusions:

• In vitro iPSC studies are critical for dissecting endocardial pathology in HLHS.
• Further research is needed to refine these models for better recapitulation of in vivo endocardial phenotypes.
• Understanding endocardial cell behavior is key to developing future therapeutic strategies for HLHS.